Blood Film Preparation, Staining and Morphology: A Training Guide for Biomedical Scientists
The peripheral blood film remains one of the most powerful, inexpensive and underrated investigations in haematology. A well-made, well-stained film examined by a competent biomedical scientist (BMS) can reveal acute leukaemia, malaria, microangiopathic haemolytic anaemia or a spurious analyser count in minutes. This guide walks NHS trainees and registered staff across Bands 2 to 8 through preparing, staining and systematically examining a blood film, recognising red cell, white cell and platelet morphology, and applying current ICSH and British Society for Haematology (BSH) guidance on when to make and review films.
Why the Blood Film Still Matters
Modern haematology analysers count and characterise cells with great precision, but they cannot replace human morphological assessment. The analyser produces numbers and flags; the film provides the picture. Even in fully automated laboratories using digital morphology systems such as CellaVision, a proportion of samples will always require a manual film and expert review.
Films are made to investigate analyser-generated flags, to follow up abnormal full blood count (FBC) parameters, and in response to specific clinical requests. The International Council for Standardization in Haematology (ICSH) and the BSH have published guidance to make this process consistent, reproducible and clinically meaningful. Working to a recognised standard is also an expectation under ISO 15189:2022, the international standard against which UKAS (United Kingdom Accreditation Service) assesses medical laboratories.
Preparing the Blood Film
A good film is the foundation of accurate morphology. Errors at the preparation stage cannot be corrected at the microscope.
Sample requirements:
- Use EDTA (ethylenediaminetetraacetic acid) anticoagulated blood, ideally examined within a few hours of venepuncture. EDTA preserves cell morphology well but storage artefacts (crenation, vacuolation, nuclear changes) increase with time and temperature.
- Films made within 1 hour give the best morphology; many laboratories make films promptly when an analyser flag is generated.
- Always check the request and patient identifiers against the sample before proceeding.
1. Place a small drop of well-mixed blood (approximately 2-3 mm diameter) about 1 cm from the end of a clean, grease-free glass slide. 2. Hold a spreader slide at an angle of around 30-45 degrees and draw it back into the drop, allowing blood to spread along its edge by capillary action. 3. Push the spreader smoothly and steadily forward in a single, even motion. 4. Aim for a film roughly 3-4 cm long with a smooth, tongue-shaped tail.
Adjusting the film: A higher spreader angle, faster push or larger drop produces a thicker film; the opposite produces a thinner one. Anaemic (low haematocrit) samples need a steeper angle or faster spread, while polycythaemic samples need a shallower angle or slower spread to achieve an even monolayer.
Features of a well-made film:
- A smooth, gradual transition from head to body to tail, with no ridges, holes or streaks.
- A defined feathered tail that does not run off the slide edge.
- An area of "spread cells" where red cells are evenly distributed, just touching but not overlapping — this is the optimal reading zone.
Romanowsky Staining
Blood films are stained using Romanowsky stains, which combine a basic dye (azure B) and an acidic dye (eosin Y) to give the characteristic polychromatic effect. The ICSH reference method, based on purified azure B and eosin Y, underpins the modern understanding of how these dyes work, and most NHS laboratories use ready-made commercial variants such as May-Grünwald-Giemsa (MGG) or Wright-Giemsa, applied manually or by automated stainers.
The chemistry in brief:
- Azure B (basic, blue) binds acidic structures: DNA, RNA and the granules of basophils.
- Eosin Y (acidic, red/orange) binds basic structures: haemoglobin and the granules of eosinophils.
- The interaction of the two dyes produces the purple "Romanowsky effect" in nuclei and neutrophil granules.
| Structure | Expected appearance | |-----------|---------------------| | Red cell cytoplasm | Pink to orange-red | | Nuclei (lymphocytes, neutrophils) | Purple to blue-purple | | Neutrophil granules | Fine, lilac/neutral | | Eosinophil granules | Bright orange-red | | Basophil granules | Dark blue-purple | | Platelets | Purple granules, pale blue cytoplasm |
Common staining faults and causes:
- Too blue (basophilic): thick film, overstaining, prolonged buffer rinse, or alkaline pH. Counterintuitively, a buffer that is too alkaline shifts everything blue.
- Too pink (eosinophilic): understaining, excessive washing, acidic pH, or inadequate buffer rinse.
- Precipitate/stain deposit: unfiltered stain, dirty slides or insufficient washing — can be mistaken for platelets or inclusions.
When to Make and Review a Film: ICSH and BSH Criteria
Not every FBC needs a film, but missing the right ones is a clinical safety issue. Two complementary frameworks guide practice.
Analyser flags and review criteria (ICSH/ISLH consensus): The International Consensus Group for Hematology Review published 41 rules defining when to take action — including blood film review — following automated FBC and white cell differential analysis. These cover both first-time samples and delta-check rules for repeat samples within a defined interval. Each NHS laboratory adapts these into validated, locally verified rules within its analyser middleware and standard operating procedures, as required under ISO 15189:2022.
Typical triggers for making a film include:
- Analyser morphology flags: blasts, atypical/variant lymphocytes, immature granulocytes, nucleated red cells (NRBC), left shift, platelet clumps.
- New or unexplained cytopenias: anaemia, neutropenia, thrombocytopenia.
- Marked leucocytosis, leucopenia or thrombocytosis.
- Pancytopenia or bicytopenia.
- Suspected haemolysis, malaria, haemoglobinopathy, or paraprotein-related changes.
- Specific clinical requests (for example, query leukaemia, query haemolysis).
- Failure of the analyser to produce a valid differential.
Systematic Examination of the Film
A disciplined, repeatable routine prevents missed findings. Examine every film the same way.
1. Low power (x10): Assess overall quality, staining, cell distribution and platelet aggregates. Scan the tail and edges for large abnormal cells, parasites, rouleaux or fibrin. Select the correct reading area. 2. High power (x40): Form an overview of red cell, white cell and platelet morphology and confirm cellularity. 3. Oil immersion (x100): Perform detailed morphology, the differential count and inclusion identification.
A morphology comment should always be correlated with the FBC indices and, where possible, the clinical details. Morphology is interpreted in context, not in isolation.
Recognising Red Cell, White Cell and Platelet Morphology
Red cells (erythrocytes) — assess size, shape, colour and inclusions:
- Size: microcytes, macrocytes, anisocytosis.
- Shape (poikilocytosis): spherocytes, target cells, schistocytes (red cell fragments), elliptocytes, sickle cells, teardrop cells (dacrocytes), pencil cells, echinocytes and acanthocytes.
- Colour: hypochromia, polychromasia (reflecting reticulocytosis).
- Inclusions/distribution: Howell-Jolly bodies, basophilic stippling, Pappenheimer bodies, malaria parasites, rouleaux and red cell agglutination.
- Neutrophils: left shift, toxic granulation, Döhle bodies, hypersegmentation, hypogranularity or Pelger-Huët/pseudo-Pelger forms.
- Lymphocytes: reactive/atypical lymphocytes, small mature lymphocytes, smear cells, villous or large granular lymphocytes.
- Monocytes, eosinophils, basophils: quantify and note morphology.
- Abnormal cells: blasts, promyelocytes, and any cell requiring referral to a senior BMS or haematologist.
- Estimate adequacy and correlate with the analyser count.
- Identify platelet clumps and platelet satellitism (often EDTA-induced), which cause spurious thrombocytopenia and may need a citrate sample.
- Note giant platelets and platelet anisocytosis.
Standardised Morphology Grading
To make reporting consistent between staff and laboratories, the ICSH recommendations for the standardisation of nomenclature and grading of peripheral blood cell morphological features provide an agreed vocabulary and a semi-quantitative grading scheme. Findings may be reported as present/absent, by simple description, or graded.
The ICSH approach grades abnormalities by the percentage of affected cells, broadly as:
| Grade | Approximate proportion of affected cells | |-------|------------------------------------------| | Normal / within reference | Below ~5% | | Mild (1+) | ~5-25% | | Moderate (2+) | ~25-50% | | Marked (3+) | Above ~50% |
For reliable percentages, a sufficient number of cells must be assessed; counting around 1000 red cells gives a precise estimate of a given abnormality, consistent with statistical distribution principles. Some findings warrant separate, more rigorous quantitation — for example, ICSH recommendations on schistocytes set a confident reporting threshold of around 1%, with the schistocyte percentage having defined diagnostic value in thrombotic microangiopathy. Using consistent nomenclature and grading supports comparability, EQA performance, and clear communication with requesting clinicians.
Quality, Competence and Documentation
Morphology is a registrant skill that must be maintained. Under HCPC (Health and Care Professions Council) standards and IBMS (Institute of Biomedical Science) frameworks, staff performing and authorising film reports work within defined competencies. Good practice includes:
- Documented training and competency assessment before independent film reporting.
- Participation in UK NEQAS blood film morphology and digital morphology schemes (EQA), alongside internal quality control of staining.
- Adherence to validated, version-controlled SOPs for film making, staining, examination and reporting.
- Clear audit trails and escalation pathways, as expected under ISO 15189:2022.
Frequently Asked Questions
What angle should I use to spread a blood film?
A spreader angle of about 30-45 degrees suits most normal samples. Increase the angle (or push faster) for anaemic samples with a low haematocrit, and decrease it (or push more slowly) for polycythaemic samples. The aim is always an even monolayer with a feathered tail in the reading area.
Why is buffer pH so important in Romanowsky staining?
The azure B and eosin Y dyes are pH-sensitive. A buffer that is too alkaline pushes the film towards blue (basophilic) staining, while a too-acidic buffer makes it appear too pink (eosinophilic). A controlled, buffered pH around 6.8 gives reproducible colour balance, which is why pH-stabilised buffer rather than tap water is used.
Which analyser flags should prompt a manual blood film?
Common triggers include flags for blasts, atypical or variant lymphocytes, immature granulocytes, nucleated red cells, platelet clumps, plus new or unexplained cytopenias, marked leucocytosis or thrombocytosis. Each laboratory builds locally validated rules from the ICSH/ISLH consensus 41-rule framework, embedded in its analyser middleware and SOPs.
How does ICSH grading of morphology work?
ICSH recommends consistent nomenclature and a semi-quantitative grade based on the proportion of affected cells, typically mild (1+, ~5-25%), moderate (2+, ~25-50%) and marked (3+, above ~50%), with normal generally below ~5%. Assessing around 1000 cells gives a reliable percentage. Some abnormalities, such as schistocytes, have specific quantitation thresholds.
What causes spurious thrombocytopenia on a film?
Platelet clumping and platelet satellitism, often induced by EDTA, can cause the analyser to under-report platelets. The film reveals the clumps. A sample collected into citrate (with appropriate correction) usually resolves the discrepancy and gives a true count.
Do digital morphology systems remove the need for manual film skills?
No. Systems such as CellaVision pre-classify cells and improve efficiency, but a competent BMS must verify and reclassify cells, interpret findings in clinical context, and handle samples the system cannot resolve. Manual morphology skill and EQA participation remain essential.
Further training
Continue building your haematology and quality skills with these PathologyLabTraining resources and the wider NHS Laboratory Training pillar:
- Result Interpretation Training: Haematology — apply morphology and FBC interpretation in realistic validation scenarios.
- Flow Cytometry Training for Biomedical Scientists — the natural next step when blood film findings suggest a haematological malignancy.
- Quality Control in the NHS Lab: EQA, IQA and IQC Explained — understand the QC and EQA frameworks that underpin staining and morphology reporting.
- UKAS and ISO 15189:2022 Accreditation Guide — see how film procedures fit within accredited laboratory practice.